MAUCH, CHRISTOF ULRICH
MAUCH, CHRISTOF ULRICH
DIPARTIMENTO DI SCIENZE SOCIALI
Mostra
records
Risultati 1 - 2 di 2 (tempo di esecuzione: 0.001 secondi).
Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study
2023 Hamid, O; Hassel, Jc; Shoushtari, An; Meier, F; Bauer, Tm; Salama, Aks; Kirkwood, Jm; Ascierto, Pa; Lorigan, Pc; Mauch, C; Orloff, M; Evans, Trj; Holland, C; Edukulla, R; Abedin, Se; Middleton, Mr
Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma
2026 Dummer, R; Sandhu, S; Miller Wh, Jr; Butler, Mo; Taylor, Mh; Heinzerling, L; Blank, Cu; Couselo, Em; Burris Ha, 3rd; Postow, Ma; Chmielowski, B; Middleton, Mr; Berking, C; Hassel, Jc; Gesierich, Ah; Mauch, C; Kleha, Jf; Polli, A; Harney, As; Di Pietro, A; Ascierto, Pa
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study | 1.1 Articolo in rivista | 2023 | Hamid, O; Hassel, Jc; Shoushtari, An; Meier, F; Bauer, Tm; Salama, Aks; Kirkwood, Jm; Ascierto, Pa; Lorigan, Pc; Mauch, C; Orloff, M; Evans, Trj; Holland, C; Edukulla, R; Abedin, Se; Middleton, Mr | |
| Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma | 1.1 Articolo in rivista | 2026 | Dummer, R; Sandhu, S; Miller Wh, Jr; Butler, Mo; Taylor, Mh; Heinzerling, L; Blank, Cu; Couselo, Em; Burris Ha, 3rd; Postow, Ma; Chmielowski, B; Middleton, Mr; Berking, C; Hassel, Jc; Gesierich, Ah; Mauch, C; Kleha, Jf; Polli, A; Harney, As; Di Pietro, A; Ascierto, Pa |